박태윤 (Harvard Medical School/McLean Hospital)님 | 한빛사연구자 > 한빛사

Harvard Medical School/McLean Hospital

최종업데이트 2024.05.24.

Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses
- Cell Res., May 22 2024, | https://doi.org/10.1038/s41422-024-00971-y
- 2024-05
- 생명과학
- 한빛사논문
Co-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease
- Nature, 12 July 2023 | https://doi.org/10.1038/s41586-023-06300-4
- 2023-07
- 생명과학
- 한빛사논문
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
- N. Engl. J. Med., May 14, 2020 vol. 382, no. 20, page. 1926-1932 | 10.1056/NEJMoa1915872
- 2020-05
- 생명과학
- 한빛사논문
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
- Proc. Natl. Acad. Sci. USA, Published online before print December 19, 2014, doi: 10.1073/pnas.1413687112
- 2014-12
- 생명과학
- 한빛사논문

연구자 ID

저자논문